QuikChange-Style PCR Site-Directed Mutagenesis to Introduce a Single Point Mutation in a Plasmid-Borne Gene

Run the mutagenesis PCR alongside a no-primer (or no-polymerase) negative control and a wild-type template control. Screen 4–6 colonies by Sanger sequencing across the mutation site and flanking region. Use 10–50 ng template, primers with Tm ≥ 78 °C (QuikChange rule) or partially overlapping primers for larger plasmids. Perform a single PCR per mutation but verify by full-insert sequencing to catch polymerase-introduced errors.

BSL-1 for standard cloning E. coli; wear gloves and lab coat. Use safer DNA stains and UV-blocking protection at the transilluminator if visualizing PCR products. Autoclave or disinfect all bacterial cultures, plates, and consumables before disposal. Standard chemical hygiene for buffers and enzymes; no special hazards beyond routine molecular-biology practice. Dispose of antibiotic-containing media per institutional guidelines.

Negative control: PCR with no primers (or no polymerase) followed by DpnI and transformation — few/no colonies confirm parental-template digestion works and there is no carryover. Wild-type template control: confirms transformation efficiency and that colonies reflect amplified product, not surviving template. Positive control: a previously successful mutagenesis or kit control to validate reagents. DpnI control: a no-DpnI mock to demonstrate the colony reduction attributable to template digestion. Sequencing is the definitive verification control.

A successful reaction yields a modest number of colonies (tens), notably more than the no-primer control. Sanger sequencing should show the intended substitution in ≥ 70% of picked clones, with clean traces and no additional mutations in the sequenced region. Low/no colonies on the no-primer control confirm effective DpnI template removal.

• Plasmid template (Dam+ E. coli-prepped, so it is methylated for DpnI selection), 10–50 ng
• High-fidelity polymerase with strong processivity (e.g., Pfu Ultra II or Q5)
• Complementary (or partially overlapping) mutagenic primer pair carrying the substitution, HPLC-purified
• dNTPs (10 mM each), 10× polymerase buffer with Mg2+
• DpnI restriction enzyme (cleaves methylated GATC)
• PCR-cleanup kit, chemically competent E. coli (DH5α or XL1-Blue), SOC
• LB agar plates with appropriate antibiotic (e.g., 100 µg/mL ampicillin)
• Nuclease-free water; thermocycler; 37 °C incubator/shaker; sequencing primers flanking the site

To create a precise point mutation in a plasmid-encoded gene by amplifying the entire plasmid with high-fidelity polymerase and complementary mutagenic primers, digesting the methylated parental template with DpnI, transforming the nicked mutant product, and confirming the intended change with no off-target mutations by Sanger sequencing. The objective is a high mutagenesis success rate (≥ 70% correct clones).

1. Design two complementary primers with the mutation centered and ≥ 10–15 correct bases on each flank; aim for Tm ≥ 78 °C and ~40–60% GC.
2. Assemble 50 µL PCR: 10–50 ng template, 0.2 µM each primer, 200 µM dNTPs, 1× buffer, high-fidelity polymerase.
3. Cycle: 95 °C 2 min; 18 cycles of 95 °C 30 s / 60 °C 1 min / 68 °C 1 min per kb of plasmid; 68 °C 5 min final.
4. Add 1 µL DpnI directly to the PCR; incubate 37 °C for 1 h to digest the methylated parental template.
5. Optionally PCR-clean; transform 2–5 µL into 50 µL competent cells: ice 30 min, 42 °C 45 s, ice 2 min.
6. Add 950 µL SOC; recover 60 min at 37 °C, 250 rpm; plate 100–200 µL on selective agar; 16 h at 37 °C.
7. Pick 4–6 colonies; miniprep plasmid DNA.
8. Sanger-sequence across the mutation site and ≥ 200 bp flanking each side using flanking primers.
9. Confirm the intended substitution and the absence of secondary mutations; archive a verified clone as a glycerol stock.

Independent variables: primer design (overlap length, Tm), template amount, and extension time. Dependent variables: colony count, fraction of clones bearing the intended mutation, and frequency of off-target mutations. Controlled variables: cycle number (≤ 18 to limit error accumulation), polymerase fidelity, DpnI digestion time, Dam-methylation status of the template, and transformation conditions. GC content and mismatch position (centered) are held in the design window.

Primers carrying the desired mismatch flanked by ≥ 10–15 matched bases on each side will direct whole-plasmid synthesis of a mutant strand; DpnI selectively digests the Dam-methylated parental plasmid, so the surviving, transformed molecules carry the intended mutation at a high frequency confirmable by sequencing.

Compare colony counts between mutagenesis and no-primer controls to confirm template digestion. Align Sanger traces to the in-silico mutant sequence in SnapGene/Benchling; verify the target codon change and scan flanking sequence for unintended mutations. Calculate percent-correct clones from those sequenced. Document the verified clone, its full read coverage over the mutation, and any silent/secondary changes.

No colonies: PCR failed or too few cycles — verify product on a gel, increase to 18–20 cycles, confirm extension time matches plasmid size. High background of wild-type: incomplete DpnI digestion or unmethylated template — ensure template from a Dam+ strain, extend DpnI to 2 h, add a second DpnI aliquot. Mutation not incorporated: poor primer design — center the mismatch, raise Tm, use HPLC-purified primers. Secondary mutations: too many cycles or low-fidelity enzyme — reduce cycles, use Q5/Pfu Ultra. Smeary/no product: extension too short for large plasmids — use 1 min/kb.

Report the mutagenesis success rate as a proportion (correct clones / clones sequenced) with a 95% binomial confidence interval. To compare primer designs or conditions, use Fisher's exact test (α = 0.05) on correct vs incorrect clone counts across ≥ 2 independent reactions. Off-target mutation frequency can be expressed per kb sequenced; with low expected error from high-fidelity polymerase, n = 4–6 sequenced clones is typically sufficient to confirm a mutation.